Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  John Wiley & Sons Inc    JW.A

JOHN WILEY & SONS INC (JW.A)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
52.75(c) 52.9(c) 54.9(c) 54.55(c) 55(c) Last
149 114 252 558 369 865 184 793 241 401 Volume
-0.19% +0.28% +3.78% -0.64% +0.82% Change
More quotes
Financials ($)
Sales 2018 1 732 M
EBIT 2018 244 M
Net income 2018 153 M
Debt 2018 -
Yield 2018 2,33%
Sales 2019 1 748 M
EBIT 2019 265 M
Net income 2019 198 M
Debt 2019 -
Yield 2019 2,44%
P/E ratio 2018 20,64
P/E ratio 2019 15,63
Capi. / Sales2018 1,80x
Capi. / Sales2019 1,78x
Capitalization 3 119 M
More Financials
Company
John Wiley & Sons, Inc.is a research company.It operates through the following segments: Research, Publishing and Solutions.The Research segment serves the world's research and scholarly communities and is the publisher for professional and scholarly societies.Its products include scientific,... 
More about the company
Surperformance© ratings of John Wiley & Sons Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on JOHN WILEY & SONS INC
10/06 JOHN WILEY & SONS INC : ex-dividend day
09/21 JOHN WILEY & SONS : Better Rechargeable Batteries Coming Soon? Hybrid indium-lit..
09/21 JOHN WILEY & SONS : Pelvic Floor Society Issues Statement on the Use of Mesh in ..
09/20 JOHN WILEY & SONS : Obesity May Adversely Affect Sperm Quality
09/20 JOHN WILEY & SONS : Certain Bone Deficits May Increase Fracture Risk in Individu..
09/20 JOHN WILEY & SONS : Radavirsen Performs Well in Early Influenza Trial
09/20 JOHN WILEY & SONS : Asthma Medication May Have Psychiatric Side Effects
09/20 JOHN WILEY & SONS : PTSD Linked with Increased Lupus Risk
09/20 JOHN WILEY & SONS : Fish May Use Different Behaviours to Protect Against Parasit..
09/20 JOHN WILEY & SONS : How Do Human Impacts on Wetlands Affect Animals?
More news
Sector news : Professional Information Services - NEC
10/17 TSX grinds higher as Bombardier soars on Airbus deal
10/12DJEquifax Hack Drives GOP Bill to Overhaul Credit Bureaus -- Update
10/12DJCybersecurity Tops Priority List For CEOs After String of High-Profile Hacks
10/10DJEQUIFAX : Hack Disclosed Driver's License Data for More Than 10 Million -- Updat..
10/04 EQUIFAX : Senate panel to hold hearing on Yahoo, Equifax breaches
More sector news : Professional Information Services - NEC
Latest Tweets
10/17John Wiley and Sons appoints Brian A. Napack as President and CEO  
10/10Analyzing Thomson Reuters Corp $TRI & John Wiley & Sons $JW.A  
10/05John Wiley & Sons, Inc. $JW.A To Go Ex-Dividend on October 6th  
10/05Get the latest ratings for $IR $JW.A $JRJC $CNS $RXII in your inbox with Mark.. 
10/01$JW.A, $CLGX - John Wiley & Sons #JW.A versus CoreLogic #CLGX Head-To.. 
More tweets
Qtime:39
News from SeekingAlpha
10/17 John Wiley and Sons appoints Brian A. Napack as President and CEO
09/28 John Wiley & Sons declares $0.32 dividend
09/19 JOHN WILEY & SONS : Still Waiting On An Attractive Bull Case
09/11 John Wiley & Sons, Inc. 2018 Q1 - Results - Earnings Call Slides
09/07 Wiley -3.2% as publishing drags on profits
Chart JOHN WILEY & SONS INC
Duration : Period :
John Wiley & Sons Inc Technical Analysis Chart | JW.A | US9682232064 | 4-Traders
Technical analysis trends JOHN WILEY & SONS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 60,3 $
Spread / Average Target 9,7%
EPS Revisions
Managers
NameTitle
Matthew S. Kissner Chairman & Chief Executive Officer
John A. Kritzmacher CFO, Executive VP-Technology & Operations
Judy K. Verses Executive Vice President-Research
William B. Plummer Independent Director
Raymond W. McDaniel Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHN WILEY & SONS INC0.92%3 119
RELX N.V.16.48%46 249
RELX16.70%46 239
S&P GLOBAL INC50.22%41 518
THOMSON REUTERS CORP2.14%34 046
EQUIFAX INC.-6.99%13 237